Dr Mohamed Jalloh is a urologist trained in Senegal (West Africa) and working as a consultant urologist at the Hopital General de Grand Yoff, Dakar and coordinating the department of Medical Information.

He has expertise in the treatment of urological cancers and research on prostate cancer in men of African descent. He contributed to running an NIH funded research project on prostate cancer under Dr Serigne Gueye co-PI in collaboration with Dr Timothy Rebbeck co-PI from University of Harvard. Such research focused on a better understanding of clinical and molecular epidemiology of prostate cancer in Senegalese men with an emphasis on developing research infrastructure.

This research was further enlarged in a consortium, the Men of African Descent Carcinoma of the Prostate (MADCaP). Dr Jalloh is Co Investigator in an NIH/NCI funded grant to MADCaP (U01CA184374 – Dr Timothy Rebbeck PI) to study the Genetic Epidemiology of Prostate Cancer in Africa in the period 2019-2024.

In 2013, he completed a UCSF/SIU post doctoral scholarship training in Urologic Oncology at the University of California San Francisco under Dr Peter R Carroll, MD and published peer reviewed papers on prostate cancer.

In 2015, he completed a Masters of Public Health: Management and Control of health programme at the University Alioune Diop of Bambey, Senegal.

Dr Mohamed Jalloh is a part time lecturer in Urology at the University Saint Christopher of Dakar and in Public health at the University Alioune Diop of Bambey.

He is the the Treasure of the Senegalese Association of Urologist ASU for the term 2018-2020.

He served as PAUSA Secretary General from 2017 to 2019 and is reappointed Secretary General for 2019-2021.